创新抗癌药
Search documents
一图读懂莱美药业2025年度ESG
新财富· 2026-03-25 08:45
Core Viewpoint - The article emphasizes the commitment of the company to high-quality development and the integration of Environmental, Social, and Governance (ESG) principles into its strategic planning and operations, aiming for sustainable growth in the pharmaceutical industry [3][4]. ESG Governance and Compliance - The company incorporates ESG management into its strategic planning, establishing a governance system led by party building and multi-level control, enhancing compliance and risk management mechanisms [5]. - The company has received several accolades, including the "Golden Information Disclosure Award" and recognition as a strong enterprise in party building in Chongqing [6]. Innovation, R&D, and Product Quality - The company focuses on innovation-driven development, increasing R&D investment to 13.55% of operating income, and ensuring product quality throughout the lifecycle [7][8]. - The company has 92 effective patents and has successfully passed the consistency evaluation for three generic drugs, with an innovative anti-cancer drug receiving clinical trial approval [9]. Environmental Management - The company aims for "dual carbon" goals, establishing a comprehensive environmental management system to promote energy conservation and emission reduction [10][11]. - Environmental performance indicators show a significant reduction in total energy consumption and hazardous waste, with zero major environmental incidents reported [12]. Supply Chain Management - The company has developed a comprehensive supplier management system, emphasizing the qualification review and responsibility requirements for suppliers, while ensuring fair treatment of small and medium enterprises [13]. Employee Development and Social Responsibility - The company prioritizes employee welfare, achieving 100% coverage in health records and occupational disease rates, and has conducted extensive training programs [16][17]. - Social contributions include a total of 161,100 yuan invested in public welfare and 76,100 yuan for rural revitalization efforts, supporting disaster relief and educational initiatives [18][19].